Compare Enovix Corporation (ENVX) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enovix Corporation vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Enovix Corporation trades at $2.51 (market cap $549.72M), while Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 22.9× Enovix Corporation's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| ENVX | HALO | |
|---|---|---|
Market Cap | $549.72M | $12.58B |
Volume | 6,635,687 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $13.19 | $115.22 |
52-Week Low | $2.50 | $61.63 |
Typical Hold Time | 11 Days | 0 Days |
Enterprise Value | $611.42M | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.55, down 5.56% on the day, reflecting a bearish technical outlook with significant selling pressure indicated by moving averages and oscillators. Fundamentally, the company is in a high-growth, pre-profitability phase, with revenue growing to $36 million in 2026 but net losses widening to -$170 million. Recent news is dominated by a sudden CEO resignation in August 2026, though the company reaffirmed its strategy and operational guidance.
The investment case hinges on the company's advanced battery technology and expansion plans, particularly in the defense and drone sectors, against a backdrop of persistent cash burn and high execution risk. Analyst consensus remains bullish with a $10.75 price target, but the stock faces near-term volatility from leadership uncertainty and the challenging path to profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
